There was a marked increase in the prevalence of targeted therapy among patients with chronic lymphocytic leukemia (CLL), ...

Payer coverage of biosimilars is always shifting as new ones come to market, explained Tasmina Hydery, PharmD, MBA, BCGP, ...

William R. Short, MD, MPH, of the University of Pennsylvania, discusses how a label update for bictegravir can help provide ...

In a session during the final full day of conference activity at AXS24, experts from CVS Health and Surescripts emphasized ...